Understanding Diseases

At Roche, we work with a purpose

Roche’s innovative pharmaceutical and diagnostic products and services fulfill unmet medical needs across a range of diseases.

We use our expertise to make a difference to the lives of patients and the healthcare professionals who care for them and to support the researchers and scientists who share our passion for fighting disease.Our pharmaceutical teams focus on tackling oncology, viral diseases, inflammation, metabolic disorders and conditions affecting the central nervous system. Our diagnostic teams are committed to the early detection, targeted screening, evaluation and monitoring of a wide range of diseases.

Roche’s rich history of ground-breaking research and development equips us with an in-depth understanding of diseases including their causes, their impact on people’s lives and how they can be diagnosed and treated.

Here is what Roche in Malaysia is currently focused on.

Pharma I Diagnostics

Oncology

Cancer being the second highest cause of death worldwide remains a major public health concern, whereby many companies are still labouring to improve cancer treatment. For more than 50 years, Roche has been developing medicines with the goal to redefine treatment in oncology. Today, we’re investing more than ever to bring personalised immunotherapy to people with cancer.

Pharma I Diagnostics

Personalized Healthcare

We are at a pivotal moment in healthcare history. An unprecedented convergence of medical knowledge, technology and data science is revolutionising patient care. Roche is spearheading the next generation of healthcare with partners around the globe. We are bringing together a unique understanding of human biology with new ways to analyse health data. Our vision is to ensure that the screening, diagnosis, treatment and even prevention of diseases will more quickly and effectively transform the lives of people everywhere - ensuring the right treatment for the right patient at the right time.

Pharma

Haemophilia

Haemophilia A is an inherited bleeding disorder where a person’s blood does not clot properly due to a lack or insufficient levels of a blood clotting protein known as factor VIII. Roche is developing novel approaches to hopefully advance the management of this serious disorder.

More 0

Pharma I Diagnostics

Neuroscience and Rare diseases

With a strong and diverse portfolio covering the most common to the rarest neurological conditions, Roche is approaching neuroscience and rare disease with the same curiosity, passion and rigor as we have done in oncology. Our mission is rooted in our formula: follow the science to improve the lives of people.

Pharma

Hematological malignancies

Cancers of the blood, also known as haematological malignancies, are categorised into different sub-groups based on the type of cells they affect. This grouping can be imagined almost like a tree with branches – with the three main branches being myeloma, leukaemia and lymphoma.

Pharma

Influenza

Influenza, or the "flu", is a highly contagious respiratory illness caused by the influenza virus.¹ It is one of the most common infectious diseases and represents a serious threat to public health. In fact, the flu causes up to 650,000 deaths around the world and is responsible for up to 5 million cases of severe disease every year.² Recognising the difference between the symptoms of the flu and those of a cold can help you know how best to manage your illness.

References
1. Centers for Disease Control and Prevention. Key facts about influenza (flu). Available from: https://www.cdc.gov/flu/about/keyfacts.htm (Accessed July 2019).
2. WHO 2018. Influenza (Seasonal). Available at: http://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal) (Accessed July 2019).